Page last updated: 2024-10-22

am 580 and HIV Infections

am 580 has been researched along with HIV Infections in 2 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhong, Y1
Wu, Y1
Liu, R1
Deng, Y1
Mallipattu, SK1
Klotman, PE1
Chuang, PY1
He, JC1
Ray, PE1

Other Studies

2 other studies available for am 580 and HIV Infections

ArticleYear
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure.
    Kidney international, 2012, Volume: 81, Issue:9

    Topics: AIDS-Associated Nephropathy; Aminopyridines; Animals; Benzamides; Benzoates; Cell Differentiation; C

2012
Can we cure HIV-1-associated nephropathy in transgenic mice?
    Kidney international, 2012, Volume: 81, Issue:9

    Topics: AIDS-Associated Nephropathy; Aminopyridines; Animals; Benzamides; Benzoates; Cyclopropanes; Female;

2012